ResearcherThe University of SydneyActive in the last 2 years
Žaklina Kovačević
Matched on ORCID iD 0000-0002-4742-4690; OpenAlex author ID A5015216800. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Silencing the Signal: The Metastasis Suppressor NDRG1 Disrupts Small Extracellular Vesicle-Mediated Crosstalk in Pancreatic Cancer. Last author DOI 10.1002/jev2.70334↗
- Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1. Last author DOI 10.3390/cancers15102779↗
- Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. Last author DOI 10.1016/j.jbc.2022.101608↗
- Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma. Last author DOI 10.1096/fj.202002279r↗
- The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells. Last author DOI 10.1093/carcin/bgy178↗
- Iron chelation: inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancreatic cancer and other tumors. First author DOI 10.1615/critrevoncog.2013007921↗
- Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy… Co-author DOI 10.1124/mol.111.073627↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiawei Chang · 2 shared papers, 2023–2026 · strength 0.57
- Des Raymond Richardson · 5 shared papers, 2011–2022 · strength 0.49
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Bekesho Geleta · 3 shared papers, 2019–2022 · strength 0.39
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Yujie Li · 1 shared paper, 2026 · strength 0.30
- Minoti Vivek Apte · 2 shared papers, 2021–2022 · strength 0.29
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Sumit Sahni · 2 shared papers, 2021–2022 · strength 0.29
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Alexander Richardson · 2 shared papers, 2013–2019 · strength 0.16
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Paper Iron chelation: inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancr… DOI 10.1615/critrevoncog.2013007921↗
- Zhihong Xu · 1 shared paper, 2021 · strength 0.12
- Marina Pajic · 1 shared paper, 2021 · strength 0.12
- Sharleen V. Menezes · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.